Evidence map›Paper›PMID 41446259›Full record

ArticlebioRxiv : the preprint server for biology2025

Neuroligin-2 is ubiquitinated by Nedd4l to control developmental astrocyte morphogenesis.

Kristina Sakers, Juan J Ramirez, Nimrod Elazar, Leykashree Nagendren, Erik Soderblom, Cagla Eroglu

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Kristina SakersDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Juan J RamirezDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Nimrod ElazarDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Leykashree NagendrenDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Erik SoderblomDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Cagla ErogluDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0002-7204-0218

Funding

New Proteomic and Genome Engineering Approaches to Decipher Astrocyte Function at SynapsesR01DA047258 · NIDA · DUKE UNIVERSITY · PI EROGLU, CAGLA, SODERLING, SCOTT H · 2018 to 2020
$2.1M
Control of Astrocyte Development and Astrocyte-Synapse InteractionsR01NS102237 · NINDS · DUKE UNIVERSITY · PI EROGLU, CAGLA · 2018 to 2022
$1.9M
Control of Astrocyte Morphogenesis and Synaptogenesis by Astrocytic NeuroliginsF32NS112565 · NINDS · DUKE UNIVERSITY · PI SAKERS, KRISTINA I · 2019 to 2021
$177k
A novel role for astrocyte-secreted synaptogenic factor Hevin/SPARCL1 in microglia-mediated synaptic pruning in response to visual experienceF31NS125985 · NINDS · DUKE UNIVERSITY · PI RAMIREZ, JUAN JOSE · 2022 to 2023
$79k
NIDA NIH HHS R01 DA047258NINDS NIH HHS F31 NS125985NINDS NIH HHS F32 NS112565NINDS NIH HHS R01 NS102237
6 · The paper itself

Abstract

Astrocytes of the central nervous system have an intricate and highly branched morphology. Proper development of perisynaptic astrocyte processes is necessary for the tripartite synapse development, maturation, and function. However, how astrocyte morphogenesis is controlled, and the specific molecules orchestrating this development are largely unknown. Previously, we identified Neuroligins (NLs) 1-3 as regulators of astrocyte morphogenesis by forming transcellular adhesions with neuronal neurexins. Here, we found that NL2 plays a non-redundant essential role in astrocyte morphogenesis. Through structure and function studies, we identified a WW-binding motif within the NL2 intracellular domain required for astrocyte morphogenesis. Using cell-specific

Identifiers

PMID41446259
PMCPMC12724466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.